GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Pharmalabs Ltd (BOM:543748) » Definitions » Current Ratio

Aarti Pharmalabs (BOM:543748) Current Ratio : 1.94 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Aarti Pharmalabs Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Aarti Pharmalabs's current ratio for the quarter that ended in Mar. 2024 was 1.94.

Aarti Pharmalabs has a current ratio of 1.94. It generally indicates good short-term financial strength.

The historical rank and industry rank for Aarti Pharmalabs's Current Ratio or its related term are showing as below:

BOM:543748' s Current Ratio Range Over the Past 10 Years
Min: 1.77   Med: 1.95   Max: 11.42
Current: 1.94

During the past 4 years, Aarti Pharmalabs's highest Current Ratio was 11.42. The lowest was 1.77. And the median was 1.95.

BOM:543748's Current Ratio is ranked better than
52.51% of 1074 companies
in the Drug Manufacturers industry
Industry Median: 1.87 vs BOM:543748: 1.94

Aarti Pharmalabs Current Ratio Historical Data

The historical data trend for Aarti Pharmalabs's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Pharmalabs Current Ratio Chart

Aarti Pharmalabs Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Current Ratio
11.42 1.77 1.95 1.94

Aarti Pharmalabs Quarterly Data
Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.95 - 2.09 - 1.94

Competitive Comparison of Aarti Pharmalabs's Current Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Pharmalabs's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarti Pharmalabs's Current Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarti Pharmalabs's Current Ratio distribution charts can be found below:

* The bar in red indicates where Aarti Pharmalabs's Current Ratio falls into.



Aarti Pharmalabs Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Aarti Pharmalabs's Current Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Current Ratio (A: Mar. 2024 )=Total Current Assets (A: Mar. 2024 )/Total Current Liabilities (A: Mar. 2024 )
=13456.4/6943.9
=1.94

Aarti Pharmalabs's Current Ratio for the quarter that ended in Mar. 2024 is calculated as

Current Ratio (Q: Mar. 2024 )=Total Current Assets (Q: Mar. 2024 )/Total Current Liabilities (Q: Mar. 2024 )
=13456.4/6943.9
=1.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aarti Pharmalabs  (BOM:543748) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Aarti Pharmalabs Current Ratio Related Terms

Thank you for viewing the detailed overview of Aarti Pharmalabs's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Pharmalabs (BOM:543748) Business Description

Traded in Other Exchanges
Address
204, Udyog Kshetra, Mulund Goregaon Link Road, 2nd floor,, Mulund West, Mumbai, MH, IND, 400080
Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. It manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives.

Aarti Pharmalabs (BOM:543748) Headlines

No Headlines